Biotech · Private company
ITB-Med LLC
Track this companyFree. Adds ITB-Med LLC to your Dealase workspace and tells you when its record changes.
Clinical trials94 recruiting or active
Pipeline programs11From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline11
- ATGPhase 2 · Kidney TransplantationClinicalTrials.gov · fetched Nov 12, 2026
- ATGPhase 2 · Renal TransplantationClinicalTrials.gov · fetched Nov 12, 2026
- belataceptPhase 2 · Renal TransplantationClinicalTrials.gov · fetched Nov 12, 2026
- CorticosteroidsPhase 2 · Renal TransplantationClinicalTrials.gov · fetched Nov 12, 2026
- Corticosteroids (CS)Phase 2 · Kidney TransplantationClinicalTrials.gov · fetched Nov 12, 2026
- MPAPhase 2 · Renal TransplantationClinicalTrials.gov · fetched Nov 12, 2026
- Mycophenolate Mofetil (MMF)Phase 2 · Kidney TransplantationClinicalTrials.gov · fetched Nov 12, 2026
- TACPhase 2 · Renal TransplantationClinicalTrials.gov · fetched Nov 12, 2026
- Tacrolimus (TAC)Phase 2 · Kidney TransplantationClinicalTrials.gov · fetched Nov 12, 2026
- TCD601Phase 2 · Kidney TransplantationClinicalTrials.gov · fetched Nov 12, 2026
- TCD601Phase 2 · Renal TransplantationClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials9
- Tolerance Through Mixed Chimerism (Sip-Tego)EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · started May 31, 2025ClinicalTrials.gov NCT06972069 · fetched Nov 12, 2026
- Evaluate the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.EARLY_PHASE1 · RECRUITING · started May 9, 2025ClinicalTrials.gov NCT06326476 · fetched Nov 12, 2026
- A Study of SIPLIZUMAB in AILD and LT PatientsPHASE1 · RECRUITING · started Sep 11, 2024ClinicalTrials.gov NCT06455280 · fetched Nov 12, 2026
- A Study of TCD601 in de Novo Renal Transplant RecipientsPHASE2 · COMPLETED · started Dec 28, 2023ClinicalTrials.gov NCT05669001 · fetched Nov 12, 2026
- Delayed Tolerance Through Mixed ChimerismPHASE1_PHASE2 · RECRUITING · started Oct 1, 2023ClinicalTrials.gov NCT05900401 · fetched Nov 12, 2026
- Siplizumab for Sickle Cell Disease TransplantPHASE1_PHASE2 · TERMINATED · started Sep 28, 2023ClinicalTrials.gov NCT06078696 · fetched Nov 12, 2026
- A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PANORAMA)PHASE2 · TERMINATED · started Jan 17, 2023ClinicalTrials.gov NCT04803006 · fetched Nov 12, 2026
- A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PERSPECTIVE)PHASE2 · TERMINATED · started Dec 14, 2022ClinicalTrials.gov NCT04803058 · fetched Nov 12, 2026
- A Dose Escalation Study in de Novo Renal TransplantationPHASE2 · COMPLETED · started May 26, 2021ClinicalTrials.gov NCT04311632 · fetched Nov 12, 2026